ArticleFrontiers in immunology2018
Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.
0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 59 citations in OpenAlex.
- Host response biomarkers of tuberculosis recurrence and treatment failure.Communications medicine · 2026Article
- Minimal immune cell subset differences in a cohort of close contacts of tuberculosis index cases.Tuberculosis (Edinburgh, Scotland) · 2025Article
- Association of T-Cell Profiles With Disease Severity, Drug-Induced Liver Injury, and Treatment Completion in Tuberculosis.The clinical respiratory journal · 2025Article
- Activation and proliferation profiles of M.tuberculosis specific dual functional CD4+T cells from smear negative pulmonary TB patients.PloS one · 2025Article
- Changes of Mycobacterium tuberculosis specific antigen-stimulated CD27European journal of medical research · 2024Article
- Exploring the Potential of Exosomes as Biomarkers in Tuberculosis and Other Diseases.International journal of molecular sciences · 2024Review
- New Insights into Biomarkers for Evaluating Therapy Efficacy in Pulmonary Tuberculosis: A Narrative Review.Infectious diseases and therapy · 2023Review
- BCG-Vaccinated Children with Contact to Tuberculosis Patients Show Delayed Conversion ofVaccines · 2023Article
- Advancing personalized medicine for tuberculosis through the application of immune profiling.Frontiers in cellular and infection microbiology · 2023Review
- Diagnosis and biomarkers for ocular tuberculosis: From the present into the future.Theranostics · 2023Review
- Evaluation of Mycobacterium tuberculosis specific antigen-stimulated CD27BMC infectious diseases · 2022Article
- Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies.Clinical microbiology reviews · 2022Review
- Tuberculosis Treatment Response Monitoring by the Phenotypic Characterization ofPathogens (Basel, Switzerland) · 2022Article
- Mycobacterium tuberculosis antigen-specific T-cell responses in smear-negative pulmonary tuberculosis patients.Clinical and experimental immunology · 2022Article
- Article
- Assessment of tuberculosis disease activity in people infected withEClinicalMedicine · 2022Article
- Article
- Using TBAg/PHA Ratio for Monitoring TB Treatment: A Prospective Multicenter Study.Journal of clinical medicine · 2022Article
- Reimagining the status quo: How close are we to rapid sputum-free tuberculosis diagnostics for all?EBioMedicine · 2022Review
- Comparison of the frequency and phenotypic profile ofFrontiers in immunology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors at 7 institutions in 4 countries.
Mohamed I M AhmedDivision of Infectious Diseases and Tropical Medicine, Klinikum of the University of Munich (LMU), Munich, Germany.
Nyanda E NtinginyaNational Institute for Medical Research-Mbeya Medical Research Center, Mbeya, Tanzania.
Gibson KibikiKilimanjaro Christian Medical Centre, Kilimanjaro Clinical Research Institute, Moshi, Tanzania.
Bariki A MtafyaNational Institute for Medical Research-Mbeya Medical Research Center, Mbeya, Tanzania.
Hadija SemvuaKilimanjaro Christian Medical Centre, Kilimanjaro Clinical Research Institute, Moshi, Tanzania.
Stellah MpagamaKilimanjaro Christian Medical Centre, Kilimanjaro Clinical Research Institute, Moshi, Tanzania.
Charles MtabhoKilimanjaro Christian Medical Centre, Kilimanjaro Clinical Research Institute, Moshi, Tanzania.
Elmar SaathoffDivision of Infectious Diseases and Tropical Medicine, Klinikum of the University of Munich (LMU), Munich, Germany.
Kathrin HeldDivision of Infectious Diseases and Tropical Medicine, Klinikum of the University of Munich (LMU), Munich, Germany.
Rebecca LooseDivision of Infectious Diseases and Tropical Medicine, Klinikum of the University of Munich (LMU), Munich, Germany.
Inge KroidlDivision of Infectious Diseases and Tropical Medicine, Klinikum of the University of Munich (LMU), Munich, Germany.
Mkunde ChachageDivision of Infectious Diseases and Tropical Medicine, Klinikum of the University of Munich (LMU), Munich, Germany.
Ulrich von BothDivision of Infectious Diseases and Tropical Medicine, Klinikum of the University of Munich (LMU), Munich, Germany.
Antelmo HauleNational Institute for Medical Research-Mbeya Medical Research Center, Mbeya, Tanzania.
Anna-Maria MekotaDivision of Infectious Diseases and Tropical Medicine, Klinikum of the University of Munich (LMU), Munich, Germany.
Martin J BoereeDepartment of Lung Diseases, Radboud University Medical Centre Nijmegen, Nijmegen, Netherlands.
Stephen H GillespieInfection and Global Health Research Division, University of St Andrews, St Andrews, United Kingdom.
Michael HoelscherDivision of Infectious Diseases and Tropical Medicine, Klinikum of the University of Munich (LMU), Munich, Germany.
Norbert HeinrichDivision of Infectious Diseases and Tropical Medicine, Klinikum of the University of Munich (LMU), Munich, Germany.
Christof GeldmacherDivision of Infectious Diseases and Tropical Medicine, Klinikum of the University of Munich (LMU), Munich, Germany.
German Center for Infection Research · DEKilimanjaro Christian Medical Centre · TZNational Institute for Medical Research · TZLudwig-Maximilians-Universität München · DELMU Klinikum · DERadboud University Medical Center · NLUniversity of St Andrews · GB
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
PhenotypeAdolescentADP-ribosyl Cyclase 1AdultAgedBiomarkersCD4-Positive T-LymphocytesFemaleFollow-Up StudiesHLA-DR AntigensHumansMaleMembrane GlycoproteinsMiddle AgedMycobacterium tuberculosisSputumADP-ribosyl Cyclase 1BiomarkersCD38 protein, humanHLA-DR AntigensMembrane GlycoproteinsTuberculinTumor Necrosis Factor Receptor Superfamily, Member 7XM1 protein, humanbiomarkerMycobacterium tuberculosis-specific T cellsserial sputum cultureTAM-TB assaytreatment monitoringtuberculosis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.